Abstract 159P
Background
The stromal component constitutes as much as 90% of pancreatic cancer specimens, dynamically interacting with the tumor and adapting into a pro-survival environment. This poses a clinical challenge, as biopsies often miss cancer by only sampling stroma. By leveraging AI and image analysis, we aim to extract informative cues from stromal interactions for novel cancer biomarker identification. This approach offers the potential for enhanced diagnostic precision and a deeper understanding of pancreatic cancer biology.
Methods
Anonymized digital scans of pancreatic cancer and chronic pancreatitis were sourced from the Centre Hospitalier de l’Université de Montréal. QuPath 0.4.3 aided slide annotation, with subsequent TIF annotation export. Staining normalization was performed via the Mitkovetta technique in Python. Our process involved deep-learning stromal segmentation, prioritizing >95% stromal tiles using Ilastik. Feature extraction was executed utilizing computer vision techniques (Haralick features), alongside the pre-trained and class-trained ImageNet deep-neural network, VGG16.
Results
Our annotated, normalized, automated, and 95% stroma-probability method generated for the training cohort 9829 cancer and 1638 mass-forming pancreatitis tiles, and 10776 cancer and 1211 pancreatitis tiles for the testing set. The table highlights the performance of the classical computer vision approach (Haralicks features extraction in RGB). Furthermore, transferring the ImageNet VGG-16 pre-trained model to our dataset managed to predict the presence of adjacent cancer at 86.6% accuracy. Table: 159P
Training | Validation | |||
Haralicks features | Cancer (N=9829) vs None (N=1638) | P | Cancer (N=10776) vs None (N=1211) | P |
RGB-F2 | +66% | 7.52 X 10-308 | +8.2% | 1.37 X 10-9 |
RGB-F15 | +54% | 3.28 X 10-272 | +8.5% | 8.57 X 10-11 |
RGB F37 | +9.6% | 2.35 X 10-294 | +2.7% | 5.02 X 10-36 |
Conclusions
We demonstrate that normalized stromal tiles could predict the presence of cancer accurately just by their morphological features at HE staining. This highlights the importance of stroma for diagnostic purposes and can serve as the basis for future studies through multiplex imaging and spatial transcriptomics.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
Vincent Quoc-Huy Trinh.
Funding
Fonds de Recherche Québec Santé.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
16P - Patient and healthcare practitioner preferences in early-stage triple-negative breast cancer treatment: A discrete choice experiment
Presenter: Jiun-I Lai
Session: Poster Display
Resources:
Abstract
17P - Initial outcomes of the ACT Now PRIME CARE for breast cancer: Prevention of Breast canceR (screening/ stage shifting) utilizing Integrated MobilE Clinics and pAtient Reported online Evaluations and Education
Presenter: Herdee Gloriane Luna
Session: Poster Display
Resources:
Abstract
18P - Optimizing premenopausal HR+ HER2–ve eBC management in India: Insights from expert consensus
Presenter: Anitha Ramesh
Session: Poster Display
Resources:
Abstract
19P - Referral patterns among breast cancer patients in county-level hospitals in China
Presenter: Ping Lu
Session: Poster Display
Resources:
Abstract
20P - Real-world treatment of HER2+ and HR+/HER2- early breast cancer in county areas of China
Presenter: Ping Lu
Session: Poster Display
Resources:
Abstract
21P - Duration of breast cancer trials: Analysis of predicted versus actual completion date
Presenter: Daniëlle Verschoor
Session: Poster Display
Resources:
Abstract
22P - Impact of an online Asian genetic risk calculator on risk perception: Cancer-related distress and uptake of genetic counselling among Malaysian breast cancer patients (The ARiCa Study)
Presenter: HEAMANTHAA Padmanabhan
Session: Poster Display
Resources:
Abstract
23P - Consensus statements and expert recommendations for BRCAm breast cancer in the Asia-Pacific region (STREAM-AP)
Presenter: Soo Chin Lee
Session: Poster Display
Resources:
Abstract
24P - Germline genetic testing for hereditary cancer: A retrospective analysis in a single site referral centre in Malaysia
Presenter: Vivian Lee
Session: Poster Display
Resources:
Abstract
25P - Clinical presentations and prognostication of HER2-low breast cancer in Taiwan
Presenter: Bo-Fang Chen
Session: Poster Display
Resources:
Abstract